A group of researchers is drawing scientific attention to “seasonal psychology,” revealing useful new ways to improve your mental and physical health, especially in winter.

The FDA has approved a new drug, zanidatamab, for adults with advanced biliary tract cancer, or BTC. Marketed under the brand name Ziihera, it is a first-of-a-kind treatment for patients with ...

Of course, many Americans now work from home (or hybrid-style). But dozens of other at-home activities are also on the rise, according to new survey data from the U.S. Census program. For the average ...

In the U.S., the least active 25% of the population over 40 could add 11 years to their average life expectancy if they were ...

About 6 in 10 people say they probably won’t get an updated shot this year, despite the CDC’s recommendation that everyone do so, according to results of a new survey from the Pew Research Center.

As the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new ...

This fall, the CDC launched a new program to help reduce diagnostic errors, a leading cause of death in the U.S. Learn how to ...

With your doctor’s recommendation, exploring yoga as a remedy for low back pain is now easier than ever – giving you the ...

The FDA has granted fast-track approval for a groundbreaking gene therapy indicated for a rare genetic disorder called ...

The critical key to weight loss success? Sustainability. No single diet or plan works for everybody, but a secret formula does exist – and it’s unique to you.

The FDA has approved a new drug called revumenib that can be taken orally to treat acute leukemia in patients 1 year or older. The drug will be marketed under the brand name Revuforj.